0001127602-15-029048.txt : 20151014 0001127602-15-029048.hdr.sgml : 20151014 20151014172930 ACCESSION NUMBER: 0001127602-15-029048 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151013 FILED AS OF DATE: 20151014 DATE AS OF CHANGE: 20151014 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Alkermes plc. CENTRAL INDEX KEY: 0001520262 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981007018 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CONNAUGHT HOUSE STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN 4 STATE: L2 ZIP: 00000 BUSINESS PHONE: 00-353-1-772-8000 MAIL ADDRESS: STREET 1: CONNAUGHT HOUSE STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN 4 STATE: L2 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: ANTLER SCIENCE TWO PLC DATE OF NAME CHANGE: 20110804 FORMER COMPANY: FORMER CONFORMED NAME: Antler Science Two Ltd DATE OF NAME CHANGE: 20110509 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FRATES JAMES M CENTRAL INDEX KEY: 0001235598 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35299 FILM NUMBER: 151158751 MAIL ADDRESS: STREET 1: 88 SIDNEY ST CITY: CAMBRIDGE STATE: MA ZIP: 021394136 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2015-10-13 0001520262 Alkermes plc. ALKS 0001235598 FRATES JAMES M CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 IRELAND 1 SVP & CFO, Alkermes plc Ordinary Shares 2015-10-13 4 M 0 10000 14.38 A 61357 D Ordinary Shares 2015-10-13 4 M 0 10000 11.74 A 71357 D Ordinary Shares 2015-10-13 4 S 0 9705 59.0929 D 61652 D Ordinary Shares 2015-10-13 4 S 0 5949 60.2025 D 55703 D Ordinary Shares 2015-10-13 4 S 0 4346 60.7166 D 51357 D Ordinary Shares 4000 I By Sons Ordinary Shares 50801 I By 2014 GRAT Ordinary Shares 41423 I By 2015 GRAT Non Qualified Stock Option (Right to Buy) 14.38 2015-10-13 4 M 0 10000 0 D 2016-12-12 Ordinary Shares 10000 0 D Employee Stock Option (Right to Buy) 11.74 2015-10-13 4 M 0 10000 0 D 2020-05-17 Ordinary Shares 10000 61983 D This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $58.51 to $59.50. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $59.52 to $60.50. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.52 to $60.94. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Shares held by James M. Frates Grantor Retained Annuity Trust dated March 14, 2014 (the "GRAT"). The Reporting Person is a trustee and beneficiary of the GRAT and may be deemed to hold voting and dispositive power with regard to the reported shares held by the GRAT. Shares held by the 2015 GRAT. The Reporting Person is a trustee and beneficiary of the 2015 GRAT and may be deemed to hold voting and dispositive power with regard to the reported shares held by the 2015 GRAT. These options are fully vested in accordance with their terms. /s/ Jennifer Baptiste, attorney-in-fact for James M. Frates 2015-10-14